Table 2.
Top Canonical Pathways for LAP1 interactors dataset.
| Name | p-Value | Overlap % | |
|---|---|---|---|
| Telomerase Signalling | 2.99 × 10−5 | 4.00% | 4/99 |
| Telomere Extension by Telomerase | 3.28 × 10−4 | 13.30% | 2/15 |
| HER-2 Signalling in Breast Cancer | 3.47 × 10−4 | 3.90% | 3/76 |
| Glioma Signalling | 6.68 × 10−4 | 3.20% | 3/95 |
| Huntington’s Disease Signalling | 7.49 × 10−4 | 1.70% | 4/229 |
Overlap represents the percentage of LAP1 interactors integrated in the total number of proteins associated to each specific pathway on the IPA Knowledge Base.